Is OrganiGram a Buy After Its Improved Q3 Results?
Canadian cannabis company OrganiGram Holdings (NASDAQ: OGI) hasn't been a great growth investment over the past year. For one thing, growth hasn't been all that strong for the company and there have even been periods in which sales were down from prior quarters. That doesn't go well with a business that's also unprofitable -- which OrganiGram is.
But investors got some good news when the company reported its most recent results on July 13 -- gross sales soared by an incredible 51% from the previous quarter. Has the business finally turned a corner, making now the time to pull the trigger and buy this pot stock?
Image source: Getty Images.
Source Fool.com
